Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
36.91
-0.61 (-1.63%)
At close: Oct 30, 2026, 4:00 PM EDT
37.00
+0.09 (0.24%)
After-hours: Oct 30, 2026, 7:53 PM EDT

Roivant Sciences Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Roivant Sciences stock has a consensus rating of "Strong Buy" and an average price target of $50. The average 1-year stock price forecast is 35.46% higher than the current stock price, while the lowest is $41 (+11.08%) and the highest is $62 (+67.98%).

Price Target: $50 (+35.46%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$41$50$51$62
Change+11.08%+35.46%+38.17%+67.98%

Analyst Ratings

The average analyst rating for Roivant Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy101099109
Buy222222
Hold111112
Sell000000
Strong Sell000000
Total131312121313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Citi
Citi
Buy
Maintains
$46 → $56
BuyMaintains$46 → $56+51.72%Oct 28, 2026
Bank of America Securities
Bank of America Securities
Hold
Maintains
$41
HoldMaintains$41+11.08%Oct 22, 2026
TD Cowen
TD Cowen
Buy
Maintains
$55 → $62
BuyMaintains$55 → $62+67.98%Oct 21, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$47
BuyMaintains$47+27.34%Oct 21, 2026
Wolfe Research
Wolfe Research
Hold
Downgrades
n/a
HoldDowngradesn/an/aOct 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
57.27M
from 8.26M
Increased by 593.33%
Revenue Next Year
428.65M
from 57.27M
Increased by 648.48%
EPS This Year
-1.56
from -1.08
EPS Next Year
-1.39
from -1.56
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
55.29M31.53M32.71M29.05M8.26M57.27M
Revenue Growth
132.34%-42.97%3.75%-11.19%-71.57%593.33%
Operating Income
-838.85M-809.01M-779.43M-1.09B-1.26B-1.34B
Net Income
-845.26M-1.01B4.35B-171.98M-299.77M-940.30M
EPS
-----1.08-1.56
Free Cash Flow
-----758.56M-950.50M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202720282029
High91.4M
Avg57.3M
Low14.1M

Revenue Growth

Revenue Growth202720282029
High
1,006.5%
Avg
593.3%
Low
70.7%

EPS Forecast

EPS202720282029
High-1.23
Avg-1.56
Low-1.89

EPS Growth

EPS Growth202720282029
High-
Avg-
Low-